دورية أكاديمية

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

التفاصيل البيبلوغرافية
العنوان: IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
المؤلفون: Socinski, Mark A., Nishio, Makoto, Jotte, Robert M., Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A., Barlesi, Fabrice, Finley, Gene, Kong, Shengchun, Lee, Anthony, Coleman, Shelley, Zou, Wei, McCleland, Mark, Shankar, Geetha, Reck, Martin
المصدر: In Journal of Thoracic Oncology November 2021 16(11):1909-1924
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2021.07.009